Výsledky vyhledávání - "Anderson AKL"

Akademický článek

Dynamic expression of Schlafen 11 (SLFN11) in circulating tumour cells as a liquid biomarker in small cell lung cancer.

Autor: Zhang B; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Stewart CA; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Q; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cardnell RJ; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Rocha P; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Fujimoto J; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Solis Soto LM; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang R; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Novegil V; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ansell P; AbbVie Inc., North Chicago, IL, USA., He L; AbbVie Inc., North Chicago, IL, USA., Fernandez L; Epic Sciences, San Diego, CA, USA., Jendrisak A; Epic Sciences, San Diego, CA, USA., Gilbertson C; Epic Sciences, San Diego, CA, USA., Schonhoft JD; Epic Sciences, San Diego, CA, USA., Byun J; Epic Sciences, San Diego, CA, USA., Jones J; Epic Sciences, San Diego, CA, USA., Anderson AKL; Epic Sciences, San Diego, CA, USA., Aparicio A; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Tran H; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Negrao MV; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zhang J; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang WL; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang J; Department of Bioinformatics & Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wenstrup R; Epic Sciences, San Diego, CA, USA., Byers LA; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Lbyers@mdanderson.org., Gay CM; Department of Thoracic/Head & Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Cgay@mdanderson.org.

Publikováno v: British journal of cancer [Br J Cancer] 2022 Aug; Vol. 127 (3), pp. 569-576. Date of Electronic Publication: 2022 Apr 19.

Zobrazit plný text záznamu

Akademický článek

Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.

Autor: Chalfin HJ; NCI, Bethesda, Maryland., Pramparo T; Epic Sciences, Inc., San Diego, California., Mortazavi A; Arthur G. James Cancer Hospital, Ohio State University Wexner Medical Center, Columbus, Ohio., Niglio SA; NCI, Bethesda, Maryland., Schonhoft JD; Epic Sciences, Inc., San Diego, California., Jendrisak A; Epic Sciences, Inc., San Diego, California., Chu YL; Epic Sciences, Inc., San Diego, California., Richardson R; Epic Sciences, Inc., San Diego, California., Krupa R; Epic Sciences, Inc., San Diego, California., Anderson AKL; Epic Sciences, Inc., San Diego, California., Wang Y; Epic Sciences, Inc., San Diego, California., Dittamore R; Epic Sciences, Inc., San Diego, California., Pal SK; City of Hope, Duarte, California., Lara PN; University of California, Davis, Sacramento, California., Stein MN; Columbia University, New York, New York., Quinn DI; University of Southern California, Los Angeles, California., Steinberg SM; NCI, Bethesda, Maryland., Cordes LM; NCI, Bethesda, Maryland., Ley L; NCI, Bethesda, Maryland., Mallek M; NCI, Bethesda, Maryland., Sierra Ortiz O; NCI, Bethesda, Maryland., Costello R; NCI, Bethesda, Maryland., Cadena J; NCI, Bethesda, Maryland., Diaz C; NCI, Bethesda, Maryland., Gulley JL; NCI, Bethesda, Maryland., Dahut WL; NCI, Bethesda, Maryland., Streicher H; NCI, Bethesda, Maryland., Wright JJ; NCI, Bethesda, Maryland., Trepel JB; NCI, Bethesda, Maryland., Bottaro DP; NCI, Bethesda, Maryland., Apolo AB; NCI, Bethesda, Maryland. andrea.apolo@nih.gov.

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2021 Mar 01; Vol. 27 (5), pp. 1391-1398. Date of Electronic Publication: 2020 Dec 01.

Zobrazit plný text záznamu

Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation

Autor: Molino, NM, Anderson, AKL, Nelson, EL, Wang, SW

Publikováno v: Molino, NM; Anderson, AKL; Nelson, EL; & Wang, SW. (2013). Biomimetic protein nanoparticles facilitate enhanced dendritic cell activation and cross-presentation. ACS Nano, 7(11), 9743-9752. doi: 10.1021/nn403085w. UC Irvine: Retrieved from: http://www.escholarship.org/uc/item/1nb80207

Many current cancer vaccine strategies suffer from the inability to mount a CD8 T cell response that is strong enough to overcome the low immunogenicity of tumors. Viruses naturally possess the sizes, geometries, and physical properties for which the

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::8e138e189f20e8247bdfa0df1ab56439
http://www.escholarship.org/uc/item/1nb80207

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání